All of the lawsuits relate to Sterigenics’ use of ethylene oxide, a potentially cancer-causing chemical, to sterilize medical devices at its Willowbrook, Ill., facility for more than 30 years. Chronic exposure to ethylene oxide can increase cancer risks and cause other major medical problems, according to the U.S. Labor Department.
The Willowbrook plant closed in September, citing the “unstable legislative and regulatory landscape in Illinois” that “created an environment in which it is not prudent to maintain these critical sterilization operations in Willowbrook.”
Romanucci & Blandin, a Chicago-based law firm, said that the new lawsuits filed against Sterigenics accuse the company of causing “leukemia, lymphoma, breast cancer, miscarriages and other medical conditions.”
Some of the lawsuits named Sotera Health, a parent company of Sterigenics, and GTCR, a hedge fund with ownership interest in the company, according to Capitol News Illinois. Some also include a maintenance supervisor and operations manager from the Willowbrook plant.
Read the full article here.
More articles on supply chain:
Walgreens, Kroger form GPO
Abbott warns of 2 potential safety issues with its heart implant
Edwards Lifesciences predicts $5B in revenue in 2020
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
